Sensitive and specific assay for the serological diagnosis of anti-p200 pemphigoid based on the recombinant laminin β4 subunit
Stephanie Goletz(University of Lübeck), Enno Schmidt(Carrier (United States)), Manuela Pigors(University of Lübeck), Lars Komorowski(Euroimmun Medizinische Labordiagnostika (Germany)), Maike M. Holtsche(University of Lübeck), Swantje Mindorf(Mayo Clinic), Detlef Zillikens(University of Lübeck), Christian Probst(Mayo Clinic), Nina van Beek(Universitäres Kinderwunschzentrum Lübeck), Wolfgang Schlumberger(Euroimmun Medizinische Labordiagnostika (Germany)), Christiane Radzimski(Euroimmun Medizinische Labordiagnostika (Germany))
Cited by 12
Related Papers
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|586
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|373
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
|Journal of the American Academy of Dermatology|2011|370
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332
Tight Clustering of Extracellular BP180 Epitopes Recognized by Bullous Pemphigoid Autoantibodies
|Journal of Investigative Dermatology|1997|309